What Are the Prospects for Moderna?

Moderna’s (NASDAQ:MRNA) revenue and profits are soaring. Its share price is up more than 280% so far this year. The company plans to build its messenger RNA (mRNA) pipeline. In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors…

Click here to view the original article.